Referral Sources
Medical oncologists refer when a cancer stops responding to a standard targeted drug, and early-phase programs draw patients who are actively looking for new studies.
Patients Exploring Protein Degraders Want to Match With You
Patients whose cancer has outgrown a standard drug are looking for what comes next. Let them find your degrader program and choose it.
Patients swipe on the practices they like. When you swipe back — it’s a match!
Free to join. No card required.
Who’s Looking
The Patients Searching for Protein Degraders
These patients are usually informed and motivated. They know their cancer’s history, they know what stopped working, and they are reading about degraders because they are looking for the next step.
On Health e Match they list their diagnosis, what they have tried and that they are exploring degrader therapy, and they meet practices that treat what they listed.
Typical Patient
An adult with advanced breast cancer, prostate cancer or a blood cancer that has developed resistance, well informed about their history and open to an early-phase study.
Your Profile
Show Patients What You Offer
Your profile is where a patient decides. Describe protein degraders the way you offer it, your clinicians and their credentials, and the regulatory status of each therapy in your own words.
- Degrader Studies by Cancer Type. Each study, its phase and its regulatory status.
- Prior Therapy Requirements. Which treatments a patient must, or must not, have had.
- Biomarker Testing. Whether a specific mutation is needed and how you test for it.
- Visit Schedule. Early-phase studies often mean frequent visits; say so plainly.
- Early-Phase Experience. Your team’s experience running first-in-human and early-phase studies.
Why Practices Join
Warm Patients, Not Cold Leads
-
Patients Make the First Move
They read your profile and swipe on you first. You’re notified the moment one does.
-
You Choose Your Patients
Swipe back on the ones who fit your practice. Pass on the ones who don’t.
-
Your Credentials Do the Talking
Your NPI is checked against the national registry, and your license and coverage are reviewed before you go live.
-
Nothing Rings the Front Desk
Messaging takes place on healthematch.com, after you’ve swiped back.
Questions
What Practices Ask
Our degrader program is early-phase. Is it a fit?
Yes. Investigational therapies are listed with the regulatory status you document, in your own words. Your study’s own rules on recruitment still apply.
Will we see a patient’s treatment history?
Patients describe what they have tried in their own profile, and you see it once they have chosen your practice.
Will patients understand what early-phase means?
Your profile is where you explain it. Investigational status is shown exactly as you document it, and patients read your profile before they choose you.
Can we list several degrader studies at once?
Yes. Describe each study you are recruiting for, each with its own regulatory status.
Start Matching Today
Build your practice profile once, list protein degraders among what you offer, and let patients who are looking for it choose you.
Free to join. No card required.
healthematch.com makes introductions between patients and practices in the United States. It does not provide medical advice, diagnosis, or treatment, does not recruit for or enroll anyone in clinical research, and does not recommend any particular procedure or provider. A practice listing an investigational therapy remains responsible for its own study’s recruitment and eligibility requirements. Looking for care? See the protein degraders page for patients.